These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 2652160
1. Predictors of compliance with lithium and carbamazepine regimens in the long-term treatment of recurrent mood and related psychotic disorders. Lenzi A, Lazzerini F, Placidi GF, Cassano GB, Akiskal HS. Pharmacopsychiatry; 1989 Jan; 22(1):34-7. PubMed ID: 2652160 [Abstract] [Full Text] [Related]
2. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients. Placidi GF, Lenzi A, Lazzerini F, Cassano GB, Akiskal HS. J Clin Psychiatry; 1986 Oct; 47(10):490-4. PubMed ID: 3093468 [Abstract] [Full Text] [Related]
3. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine]. Dardennes R, Lafuma A, Watkins S. Encephale; 1999 Oct; 25(5):391-400. PubMed ID: 10598301 [Abstract] [Full Text] [Related]
4. Carbamazepine versus lithium in mania: a double-blind study. Lerer B, Moore N, Meyendorff E, Cho SR, Gershon S. J Clin Psychiatry; 1987 Mar; 48(3):89-93. PubMed ID: 3546274 [Abstract] [Full Text] [Related]
5. The long-term management of bipolar disorders with lithium, carbamazepine, and antidepressants. Fawcett J, Kravitz HM. J Clin Psychiatry; 1985 Feb; 46(2):58-60. PubMed ID: 3968046 [Abstract] [Full Text] [Related]
6. Electrooculography and dark adaptation in patients with affective and schizoaffective psychoses: early physiological effects of carbamazepine and lithium. Kaschka WP, Thürauf N, Mokrusch T, Korth M. Pharmacopsychiatry; 1988 Nov; 21(6):404-6. PubMed ID: 3244776 [No Abstract] [Full Text] [Related]
7. Quality of interepisodic periods in patients with affective disorders under long-term lithium treatment. Volk J, Müller-Oerlinghausen B. Pharmacopsychiatry; 1988 Nov; 21(6):426-7. PubMed ID: 3244784 [No Abstract] [Full Text] [Related]
8. [Carbamazepine in manic syndromes. A controlled double-blind study]. Gonçalves N, Stoll KD. Nervenarzt; 1985 Jan; 56(1):43-7. PubMed ID: 3883202 [No Abstract] [Full Text] [Related]
11. Carbamazepine as adjunct or alternative to lithium in the prophylaxis of recurrent affective disorders. Fritze J, Beneke M, Lanczik M, Schneider B, Walden J. Pharmacopsychiatry; 1994 Sep; 27(5):181-5. PubMed ID: 7838887 [Abstract] [Full Text] [Related]
13. Therapy of affective disorders. Alexander B, Cook B. Prim Care; 1990 Sep; 17(3):565-88. PubMed ID: 2236337 [Abstract] [Full Text] [Related]
14. [Investigation on the therapeutic effect of carbamazepine on the mood disorders in Japan]. Okuma T. Seishin Shinkeigaku Zasshi; 2005 Sep; 107(5):415-22. PubMed ID: 15981617 [Abstract] [Full Text] [Related]
18. Carbamazepine in treatment and prophylaxis of manic-depressive disorder. Strömgren LS, Boller S. Psychiatr Dev; 1985 Jul 28; 3(4):349-67. PubMed ID: 3912763 [Abstract] [Full Text] [Related]
19. Rational polypharmacy in the bipolar affective disorders. Post RM, Ketter TA, Pazzaglia PJ, Denicoff K, George MS, Callahan A, Leverich G, Frye M. Epilepsy Res Suppl; 1996 Jul 28; 11():153-80. PubMed ID: 9294735 [Abstract] [Full Text] [Related]